BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 27325848)

  • 1. Randomized Noninferiority Trial of Telephone Delivery of BRCA1/2 Genetic Counseling Compared With In-Person Counseling: 1-Year Follow-Up.
    Kinney AY; Steffen LE; Brumbach BH; Kohlmann W; Du R; Lee JH; Gammon A; Butler K; Buys SS; Stroup AM; Campo RA; Flores KG; Mandelblatt JS; Schwartz MD
    J Clin Oncol; 2016 Aug; 34(24):2914-24. PubMed ID: 27325848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expanding access to BRCA1/2 genetic counseling with telephone delivery: a cluster randomized trial.
    Kinney AY; Butler KM; Schwartz MD; Mandelblatt JS; Boucher KM; Pappas LM; Gammon A; Kohlmann W; Edwards SL; Stroup AM; Buys SS; Flores KG; Campo RA
    J Natl Cancer Inst; 2014 Dec; 106(12):. PubMed ID: 25376862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancer.
    Schwartz MD; Valdimarsdottir HB; Peshkin BN; Mandelblatt J; Nusbaum R; Huang AT; Chang Y; Graves K; Isaacs C; Wood M; McKinnon W; Garber J; McCormick S; Kinney AY; Luta G; Kelleher S; Leventhal KG; Vegella P; Tong A; King L
    J Clin Oncol; 2014 Mar; 32(7):618-26. PubMed ID: 24449235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized Noninferiority Trial of Telephone vs In-Person Genetic Counseling for Hereditary Breast and Ovarian Cancer: A 12-Month Follow-Up.
    Interrante MK; Segal H; Peshkin BN; Valdimarsdottir HB; Nusbaum R; Similuk M; DeMarco T; Hooker G; Graves K; Isaacs C; Wood M; McKinnon W; Garber J; McCormick S; Heinzmann J; Kinney AY; Schwartz MD
    JNCI Cancer Spectr; 2017 Sep; 1(1):pkx002. PubMed ID: 31304457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic Testing in a Population-Based Sample of Breast and Ovarian Cancer Survivors from the REACH Randomized Trial: Cost Barriers and Moderators of Counseling Mode.
    Steffen LE; Du R; Gammon A; Mandelblatt JS; Kohlmann WK; Lee JH; Buys SS; Stroup AM; Campo RA; Flores KG; Vicuña B; Schwartz MD; Kinney AY
    Cancer Epidemiol Biomarkers Prev; 2017 Dec; 26(12):1772-1780. PubMed ID: 28971986
    [No Abstract]   [Full Text] [Related]  

  • 6. Patient and genetic counselor perceptions of in-person versus telephone genetic counseling for hereditary breast/ovarian cancer.
    Jacobs AS; Schwartz MD; Valdimarsdottir H; Nusbaum RH; Hooker GW; DeMarco TA; Heinzmann JE; McKinnon W; McCormick SR; Davis C; Forman AD; Lebensohn AP; Dalton E; Tully DM; Graves KD; Similuk M; Kelly S; Peshkin BN
    Fam Cancer; 2016 Oct; 15(4):529-39. PubMed ID: 26969308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic review and meta-analysis of telephone vs in-person genetic counseling in BRCA1/BRCA2 genetic testing.
    Bracke X; Roberts J; McVeigh TP
    J Genet Couns; 2021 Apr; 30(2):563-573. PubMed ID: 33131182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telephone genetic counseling for high-risk women undergoing BRCA1 and BRCA2 testing: rationale and development of a randomized controlled trial.
    Peshkin BN; Demarco TA; Graves KD; Brown K; Nusbaum RH; Moglia D; Forman A; Valdimarsdottir H; Schwartz MD
    Genet Test; 2008 Mar; 12(1):37-52. PubMed ID: 18373403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intentions for risk-reducing surgery among high-risk women referred for BRCA1/BRCA2 genetic counseling.
    Tong A; Kelly S; Nusbaum R; Graves K; Peshkin BN; Valdimarsdottir HB; Wood M; McKinnon W; Garber J; McCormick SR; Jandorf L; Schwartz MD
    Psychooncology; 2015 Jan; 24(1):33-9. PubMed ID: 24839250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of decision aids for female BRCA1 and BRCA2 mutation carriers: a systematic review.
    Krassuski L; Vennedey V; Stock S; Kautz-Freimuth S
    BMC Med Inform Decis Mak; 2019 Aug; 19(1):154. PubMed ID: 31370837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing.
    Lerman C; Biesecker B; Benkendorf JL; Kerner J; Gomez-Caminero A; Hughes C; Reed MM
    J Natl Cancer Inst; 1997 Jan; 89(2):148-57. PubMed ID: 8998184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic Evaluation Alongside a Clinical Trial of Telephone Versus In-Person Genetic Counseling for BRCA1/2 Mutations in Geographically Underserved Areas.
    Chang Y; Near AM; Butler KM; Hoeffken A; Edwards SL; Stroup AM; Kohlmann W; Gammon A; Buys SS; Schwartz MD; Peshkin BN; Kinney AY; Mandelblatt JS; Chang Y; Near AM; Butler KM; Hoeffken A; Edwards SL; Stroup AM; Kohlmann W; Gammon A; Buys SS; Schwartz MD; Peshkin BN; Kinney AY; Mandelblatt JS
    J Oncol Pract; 2016 Jan; 12(1):59, e1-13. PubMed ID: 26759468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Nelson HD; Pappas M; Cantor A; Haney E; Holmes R
    JAMA; 2019 Aug; 322(7):666-685. PubMed ID: 31429902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: a randomized controlled trial.
    Green MJ; Peterson SK; Baker MW; Harper GR; Friedman LC; Rubinstein WS; Mauger DT
    JAMA; 2004 Jul; 292(4):442-52. PubMed ID: 15280342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MAGENTA (Making Genetic testing accessible): a prospective randomized controlled trial comparing online genetic education and telephone genetic counseling for hereditary cancer genetic testing.
    Rayes N; Bowen DJ; Coffin T; Nebgen D; Peterson C; Munsell MF; Gavin K; Lechner R; Crase J; Polinsky D; Romero I; Blank SV; Levine DA; Norquist BM; Swisher EM; Lu KH
    BMC Cancer; 2019 Jul; 19(1):648. PubMed ID: 31266460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized controlled trial of a psychosocial telephone counseling intervention in BRCA1 and BRCA2 mutation carriers.
    Graves KD; Wenzel L; Schwartz MD; Luta G; Wileyto P; Narod S; Peshkin BN; Marcus A; Cella D; Emsbo SP; Barnes D; Halbert CH
    Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):648-54. PubMed ID: 20200423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disparities in uptake of BRCA1/2 genetic testing in a randomized trial of telephone counseling.
    Butrick M; Kelly S; Peshkin BN; Luta G; Nusbaum R; Hooker GW; Graves K; Feeley L; Isaacs C; Valdimarsdottir HB; Jandorf L; DeMarco T; Wood M; McKinnon W; Garber J; McCormick SR; Schwartz MD
    Genet Med; 2015 Jun; 17(6):467-75. PubMed ID: 25232856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient Perceptions of Telephone vs. In-Person BRCA1/BRCA2 Genetic Counseling.
    Peshkin BN; Kelly S; Nusbaum RH; Similuk M; DeMarco TA; Hooker GW; Valdimarsdottir HB; Forman AD; Joines JR; Davis C; McCormick SR; McKinnon W; Graves KD; Isaacs C; Garber J; Wood M; Jandorf L; Schwartz MD
    J Genet Couns; 2016 Jun; 25(3):472-82. PubMed ID: 26455498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of participation in psychosocial telephone counseling following genetic testing for BRCA1 and BRCA2 mutations.
    Halbert CH; Wenzel L; Lerman C; Peshkin BN; Narod S; Marcus A; Corio C; Demarco T; Bellamy S
    Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):875-81. PubMed ID: 15159322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.
    ; Owens DK; Davidson KW; Krist AH; Barry MJ; Cabana M; Caughey AB; Doubeni CA; Epling JW; Kubik M; Landefeld CS; Mangione CM; Pbert L; Silverstein M; Simon MA; Tseng CW; Wong JB
    JAMA; 2019 Aug; 322(7):652-665. PubMed ID: 31429903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.